Interim Report January - March 2021: Strong first quarter in sales as well as net result


January - March

  • Net sales increased with +6.2 procent to SEK 70.4 (66.2) million (+13 percent in local currencies).
  • EBIT amounted to SEK 6.0 (-8.8) million.
  • EBIT margin was 8.5 (-13.2) percent.
  • Profit after tax amounted to SEK 6.5 (-8.5) million.
  • Earnings per share before/after dilution amounted to SEK 0.35 (-0.46).
  • Cash flow from operating activities amounted to SEK 9.4 (9.2) million.
  • Cash and cash equivalents at the end of the period amounted to SEK 111.1 (71.5) million.

The first quarter of 2021 was a strong quarter for MSAB. In terms of sales, we delivered the best quarter in the Company’s history, SEK 70.4 (66.2) million. The bottom line, for a quarter that historically has been our weakest due to the seasonal variation we have in sales, was SEK 6.5 (-8.8) million.

This strong quarter, together with three out of four strong quarters in 2020, sets the stage for continued growth in 2021. I am happy to report that one year after the pandemic afflicted the world, MSAB has a solid financial foundation and remains the market leader. We’ve adopted our way of working, which is a key contributor to our strong global sales and cash flow.

When it comes to our global sales, EMEA, and especially Europe, accounted for the largest growth. We have a strong presence in this region, a broad customer base, and our result, as well as the feedback we receive from customers old and new, confirms our leading position. We are convinced that we will continue to grow in EMEA in 2021.

Last year we decided to reorganize our North American organization to ensure that we can fully realize the enormous potential we see on the North American market. Now that the new organization is in place, we are already beginning to see the results and we are convinced that we will see even more progress and growth throughout the rest of the year.

As we enter the second quarter, most of our customers remain in some form of lock-down, which means that they are unable to receive visitors, travel to suppliers for training, or meet for any other purpose for that matter. This situation means that some of the more major business deals we expect in 2021 are delayed. Exactly as we did for most of 2020, we continue to adapt and overcome these obstacles so we can meet our customers.

One of the ways we have overcome the barriers that the pandemic has thrown up is through the MSAB studio we have built, from where we send live updates, conduct customer meetings, and arrange other virtual events. The feedback we have received for this new approach has been phenomenal. I believe that MSAB is best-in-class when it comes to developing innovative ways to face new challenges, and our studio is a fantastic example of just this.

Demand in the industry for products like XRY continues to grow as the need for fast extraction of data, and for accuracy in the analysis of said data, is more important than ever. The ever-increasing quantity of data and the complexity of extracted information also creates new challenges within this sector, challenges that MSAB – through its products and services – is uniquely positioned to solve.

We are also proud to have the strongest platform in the industry in the face of ever-growing cyber threats. Our file format makes it impossible to change extracted data. The standard we have set for data, i.e., that it can be verified and validated, and the log files which are automatically generated, represent yet another level of security, which sets the industry standard.

MSAB also continues to lead when it comes to personal integrity.

We were encouraged to participate in the EU’s FORMOBILE project which began 18 months ago. This project will set the future standard for mobile forensics by making extraction more secure than ever before, while at the same time protecting personal integrity.

The purpose of this project is to create an end-to-end mobile forensic investigation chain, striving to improve digital safety and security from the confiscation of a mobile device all the way to producing presentable evidence. As the digital evidence becomes more crucial, the regulations for integrity and traceability increases.  We are proud to be able to contribute and help set the future standard for EU in this important matter. Bottomline, it is about preserving human rights.

This initiative builds on MSAB’s long-term leading position to provide a platform that does not just protect the reliability of extracted data, but which also protects the individual’s integrity. MSAB’ s key role in this important project is proof of our reputation and of the high standards we have for integrity and social responsibility for ourselves and for the tools we provide.

We are immensely proud of the steps we have taken thus far in 2021 and will maintain the same pace during the second quarter and the rest of the year to take advantage of the momentum that we clearly see we have.

Stockholm, April 2021

Joel Bollö, Chief Executive Officer

The information in this report is such that MSAB, Corporate ID number 556244-3050, is required to disclose in accordance with the EU’s Market Abuse Regulation. The information in this report was submitted for publication on 29 April, 2021 at 08:00 CEST.

Questions should be addressed to:
Chief Executive Officer Joel Bollö
Tel. +46 8 739 0270

MSAB in brief

MSAB is a world leader in mobile forensics technology with the aim of extracting and analysing data from confiscated mobile devices, mainly from mobile phones. The Company has its own sales offices and sales representatives in Europe, North America, South America, Australia, Singapore, Japan, India and Russia, and together with a number of distributors, covers most of the world. The proprietary products have become a de facto standard in the field and are used for securing evidence in more than 100 countries. These products are complemented by a wide range of training courses with the possibility of becoming certified in a forensically sound methodology. Customers are primarily law enforcement agencies, such as police, military and customs. MSAB is listed on NASDAQ Stockholm under the ticker symbol: MSAB B.


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Novo Nordisk A/S – Share repurchase programme7.5.2021 21:31:30 CEST | Press release

Bagsværd, Denmark, 7May2021 — As part of the up to DKK 18 billion 2021 share repurchase programme, Novo Nordisk A/S has now initiated a new share repurchase programme for an amount of up to DKK 3.3 billion in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the "Safe Harbour Rules”). For that purpose, Novo Nordisk A/S has appointed Skandinaviska Enskilda Banken, Danmark, filial af Skandinaviska Enskilda Banken AB, as lead manager to execute the programme independently and without influence from Novo Nordisk A/S. The purpose of the programme is to reduce the company’s share capital and to meet obligations arising from share-based incentive programmes. Under the agreement, Skandinaviska Enskilda Banken, Danmark, filial af Skandinaviska Enskilda Banken AB, will repurchase B shares on behalf of Novo Nordisk A/S during the trading period starting 10 May 20

Novo Nordisk A/S purchases B shares worth DKK 2,586 million from Novo Holdings A/S under the 2021 share repurchase programme7.5.2021 21:24:00 CEST | Press release

Bagsværd, Denmark, 7 May2021 — Novo Nordisk A/S has today entered into an agreement to purchase 5,610,000 B shares of DKK 0.20 to a value of DKK 2,586 million from Novo Holdings A/S. This transaction is part of Novo Nordisk A/S’ 2021 share repurchase programme of up to a total of DKK 18 billion to be executed during a 12-month period beginning 3 February 2021. The transaction price is DKK 461.04 per share and has been calculated as the three-day volume weighted average market price from 5 May 2021 to 7 May 2021 in the open window following the announcement of Novo Nordisk A/S’ quarterly financial results. Prior to the sale of B shares, Novo Holdings A/S’ ownership of Novo Nordisk A/S was 28.5% of the share capital and 76.9% of the votes. Following the transaction, Novo Holdings A/S owns 537,436,000 A shares of DKK 0.20 and 116,129,000 B shares of DKK 0.20, corresponding to 28.3% of the capital and 76.8% of the votes in Novo Nordisk A/S. The transaction is in line with the announcement

RomReal: Mandatory notification of insider trade - Chairman and CEO of RomReal Kjetil Gronskag7.5.2021 19:34:48 CEST | Press release

Kjetil Gronskag, Chairman and CEO of RomReal Ltd has today 07 May 2021, purchased 2000 shares of RomReal at NOK 1.74 per share in RomReal Ltd. Following this trade, Kjetil Gronskag controls privately and through holding companies 4,546,127 shares in RomReal Ltd. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act

PRFOODS NOTICE OF NOTEHOLDERS’ MEETING7.5.2021 16:58:01 CEST | Press release

AS PRFoods (registry code 11560713, registered address at Pärnu mnt 141, 11314 Tallinn, Estonia; “PRFoods”) hereby notifies persons holding the notes (the “Noteholders”) of the Issuer, due on 22 January 2025 and bearing ISIN code EE3300001577 (the “Notes”), issued under the Terms and Conditions of Secured Note Issue of AS PRFoods dated 14 January 2020 (which have been amended on 25 February 2020; the “Terms”), of convening a meeting of Noteholders (the “Meeting”). The Meeting will be held on 24 May 2021 at 12:00 (EET) at Peetri 12 (Kai Kunstikeskus), 10415 Tallinn, Estonia. Registration for the Meeting will be open at the venue of the Meeting from 11:00 to 11:45 (EET). The management of PRFoods requests all Noteholders to consider that due to COVID-19 caused by the coronavirus, it is advised to minimise the extent of physical gatherings and the participation therein. For this purpose, the management of PRFoods advises to consider authorising representatives of the collateral agent to p

AS PRFoods is Planning an Issue of Subordinated Convertible Notes and Tap-Issue of Secured Notes7.5.2021 16:44:03 CEST | Press release

THIS NOTICE IS NOT INTENDED FOR PUBLICATION, ALLOCATION OR TRANSMISSION, IN PART OR WHOLLY, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, OR ELSEWHERE THE DISCLOSURE OR TRANSMISSION OF THIS INFORMATION IS NOT ALLOWED. AS PRFoods (registry code 11560713, “PRFoods”) announces that due to the continuing pandemic caused by COVID-19 and the extraordinary effects the pandemic and the measures implemented to combat the pandemic have had on the economic environment, including on the economic operations of PRFoods during the pending 2020/2021 financial year (i.e. the financial year 01.07.2020 – 30.06.2021), PRFoods deems necessary to reinforce its capital structure for the purposes of ensuring a smoother and faster recovery from the negative impacts caused by COVID-19 in the upcoming 2021/2022 financial year (i.e. financial year 01.07.2021 – 30.06.2022). In connection with the above, PRFoods hereby informs that, for the


Bid procedure, 2021-05-12BondsBonds issued in SEK by Swedish non-financial undertakings. The following bonds are eligible for delivery: ELLEVIO AB: XS1562583937, 2024-02-28 HUSQVARNA AB: SE0013359486, 2024-12-04 HUSQVARNA AB: SE0010869677, 2023-02-14 LUNDBERGFORETAGEN AB: SE0012676609, 2025-11-13 LUNDBERGFORETAGEN AB: SE0009241524, 2023-10-24 WILLHEM AB: SE0012193985, 2025-02-22 WILLHEM AB: SE0013882966, 2024-04-08 CASTELLUM AB: SE0011062827, 2023-05-17 CASTELLUM AB: SE0012675916, 2025-11-27 Delivery of a Bond may not occur if the Counterparty has purchased the Bond from the issuer more recently than one month prior to the date of announcement of the Special terms, that is, the purchase may not have taken place after: 2021-04-12Bid date2021-05-12Bid times10.00-11.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)XS1562583937: 30 mln SEK +/-30 mln SEK SE0013359486: 30 mln SEK +/-30 mln SEK SE0010869677: 30 mln SEK +/-30 mln SEK SE0012676609: 30 mln SEK +/-30 ml


Bid procedure, 2021-05-14BondsSWEDEN I/L BOND: 3113. SE0009548704. 2027-12-01 SWEDEN I/L BOND: 3111, SE0007045745, 2032-06-01 Bid date2021-05-14Bid times09.00-10.00 (CET/CEST) on the Bid dateRequested volume (corresponding nominal amount)3113: 500 mln SEK +/-250 mln SEK 3111: 500 mln SEK +/-250 mln SEK Highest permitted bid volume (corresponding nominal amount)3113: 500 mln SEK per bid 3111: 500 mln SEK per bid Lowest permitted bid volume (corresponding nominal amount)SEK 50 million per bidExpected allocation timeNot later than 10.15 (CET/CEST) on the Bid dateDelivery and payment date2021-05-18Delivery of bondsTo the Riksbank's account in Euroclear Sweden AB's securities settlement system 1 4948 6383 Stockholm, 2021-05-07 This is a translation of the special terms and conditions published on In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be